The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy. A C Fiagan Y, Bossuyt E, Nevens D, Machiels M, et al. Radiother Oncol 2023 Apr 19:109676. doi: 10.1016/j.radonc.2023.109676.

Read + Share

Amedeo Smart

Independent Medical Education

A C Fiagan Y, Bossuyt E, Nevens D, Machiels M, et al. The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy. Radiother Oncol 2023 Apr 19:109676. doi: 10.1016/j.radonc.2023.109676.
PMID: 37084887